Inactive Instrument

Abiomed, Inc.

ABMD

US0036541003

Advanced Medical Equipment & Technology

Abiomed, Inc.(NasdaqGS:ABMD) dropped from NASDAQ Composite Index

December 22, 2022 at 12:00 am EST

Abiomed, Inc. removed from Nasdaq Composite Index

Latest news about Abiomed, Inc.

Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium	23-10-23	CI
ABIOMED, Inc. Announces Termination of Todd A. Trapp as Chief Financial Officer	22-12-22	CI
ABIOMED, Inc. Announces Management Changes	22-12-22	CI
ABIOMED, Inc. Announces Termination of Michael R. Minogue as Chief Executive Officer	22-12-22	CI
Johnson & Johnson Closes Acquisition of Abiomed	22-12-22	MT
Abiomed, Inc.(NasdaqGS:ABMD) dropped from NASDAQ Composite Index	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global 1200	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Healthcare Equipment Select Industry Index	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment & Services (Industry Group)	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment & Supplies	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Composite 1500	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment (Sub Ind)	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Growth	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Equal Weighted	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P TMI Index	22-12-22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global BMI Index	22-12-22	CI
Johnson & Johnson completed the acquisition of Abiomed, Inc..	22-12-21	CI
Abiomed Says US FDA Approves Impella ECP Pivotal Heart Pump	22-12-21	MT
Abiomed Announces United States Food and Drug Administration Approves Version of Impella ECP	22-12-21	CI
Steel Dynamics to Join S&P 500; Super Micro Computer to be Added to S&P MidCap 400	22-12-20	MT
Johnson & Johnson Extends Abiomed Tender Offer to Dec. 21	22-12-14	MT
Abiomed, Inc.(NasdaqGS:ABMD) dropped from FTSE All-World Index	22-12-14	CI

Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows: - sale of products (95.4%): heart pumps (Impella brand); - sale of services (4.6%): including preventive maintenance services. Net sales are distributed geographically as follows: the United States (81.2%), Europe (12.8%), Japan (5%) and other (1%).

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+8.78%	220B
DANAHER CORPORATION	+8.24%	185B
INTUITIVE SURGICAL, INC.	+11.16%	133B
BOSTON SCIENTIFIC CORPORATION	+26.12%	107B
SIEMENS HEALTHINEERS AG	+0.30%	62.91B
EDWARDS LIFESCIENCES CORPORATION	+16.21%	53.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.63%	47.71B
AGILENT TECHNOLOGIES, INC.	-1.11%	40.29B
GE HEALTHCARE TECHNOLOGIES INC.	+12.16%	39.57B

Other Advanced Medical Equipment & Technology

Abiomed, Inc.

Equities

ABMD

US0036541003

Advanced Medical Equipment & Technology

Abiomed, Inc.(NasdaqGS:ABMD) dropped from NASDAQ Composite Index

Latest news about Abiomed, Inc.

Chart Abiomed, Inc.

Company Profile

Sector Other Advanced Medical Equipment & Technology